Labshake search
Citations for BioLegend :
1 - 50 of 2852 citations for Mono 2 Ethyl 5 Oxohexyl Phthalate 13C4 99% Dehp Metabolite Vi 100Ug Ml In Mtbe since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... 5 ng/mL IL-2 (Biolegend 575404) was added to media and cells were cultured another 2 days (Lutz et al. ...
-
bioRxiv - Immunology 2022Quote: ... and 5 ng/mL IL-2 (Biolegend 575404) at 1×107 cells/mL for 72 hrs ...
-
bioRxiv - Immunology 2024Quote: ... Brefeldin A (5 μg/ml) and Monensin (2 μM) (BioLegend) were added to the cultures during the last 4 h of incubation to allow intracellular cytokine accumulation ...
-
bioRxiv - Immunology 2021Quote: ... or 5 μg/ml anti-human TRAIL antibody (RIK-2, Biolegend). After 2 h of preincubation effector cells were added to target cells.
-
bioRxiv - Cancer Biology 2022Quote: ... TGFß (1 ng/ml; cat#763102) and IL-2 (5 ng/ml, cat# 575402; All Biolegend) were added along with T cell media (RPMI ...
-
bioRxiv - Microbiology 2019Quote: ... the splenocytes were incubated for 2 h with 5 μg/ml brefeldin A (Biolegend) for intracellular trapping of cytokines and then stained with Zombie Aqua (1:200 ...
-
bioRxiv - Neuroscience 2020Quote: ... Mbp (RRID:AB_2564741, 1:500, Biolegend, SMI-99,), SMI312 (RRID:AB_2135329 ...
-
bioRxiv - Neuroscience 2020Quote: ... Mbp (1:500, RRID:AB_2564741, #SMI-99, Biolegend), TCF7l2 (1:200 ...
-
bioRxiv - Immunology 2022Quote: ... followed by stimulation with plate bound anti-CD3 (2 μg/ml) and anti-ICOS (5 μg/ml; C398.4A; Biolegend) for 24 hours.
-
bioRxiv - Bioengineering 2022Quote: ... 100 IU/mL recombinant human IL-2 (Proleukin, Prometheus Laboratories) and 5 ng/mL recombinant human IL-7 (BioLegend) at 37C ...
-
bioRxiv - Immunology 2021Quote: ... 5 ng/ml IL-5 (Biolegend; 581504), and 20 ng/ml IL-2 (Biolegend ...
-
bioRxiv - Immunology 2023Quote: ... streptavidin cyanine 5 (5 μg/mL, BioLegend) for 1 h ...
-
bioRxiv - Cancer Biology 2022Quote: ... FACS buffer recipe was D-PBS + 5% FBS + 2% BSA + 5 mM EDTA + 50 µg/ml DNase-I with Human Trustain (Biolegend, 422302). All the compensation was done using UltraComp eBeads™ Compensation Beads (Invitrogen ...
-
bioRxiv - Immunology 2020Quote: ... with 100ug of antibodies against specific human NK cells expressing NKp46 Domain 1 (Biolegend, 9E2) and/or human CD8α (Bioxcell ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 5 % human AB serum (Gemini Bio) and 30 U / mL recombinant human IL-2 (BioLegend) [9] ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 5 % human AB serum (Gemini Bio) and 30 U / mL recombinant human IL-2 (BioLegend). The viability of NALM6-GL cells was then assessed by adding 150 ug / mL D-Luciferin (PerkinElmer ...
-
bioRxiv - Immunology 2023Quote: ... rhIL-2 (50 Uml-1, Novartis) and anti-mIFN-γ (5 µg ml-1, clone XMG1.2, Biolegend) in the presence or absence of 30 mM NaCl ...
-
bioRxiv - Immunology 2019Quote: ... Brefeldin (5 mg/ml, Biolegend) and PMA (phorbol 12-myristate 13-acetate ...
-
bioRxiv - Immunology 2022Quote: ... 5% CO2 and 5 μg/mL Brefeldin A (BFA; BioLegend) was added during the last 6 h of stimulation ...
-
bioRxiv - Cancer Biology 2021Quote: ... 5 μg/mL Brefeldin A (BioLegend) was added to each sample ...
-
bioRxiv - Cancer Biology 2020Quote: ... 5 μg/mL brefeldin A (Biolegend) was added to one column of wells 18 hours prior to collection to serve as negative controls ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... 5 ng/ml TGFβ (Biolegend #580702) ± inhibitors ...
-
bioRxiv - Immunology 2021Quote: ... 5 ng/ml TGF-β1 (Biolegend), 20 ng/ml IL-23 (Miltenyi) ...
-
bioRxiv - Immunology 2020Quote: ... and .5 ug/ml αCD28 (Biolegend) for two hours before culturing with target CD4+ T-cells ...
-
bioRxiv - Immunology 2022Quote: ... α-CD28 (5 µg/ml) (37.51, BioLegend) and human Fc-ICAM-1 (50 µg/ml ...
-
bioRxiv - Immunology 2022Quote: ... IL-12 (5 ng/ml) (BioLegend) for TH1 cells ...
-
bioRxiv - Immunology 2023Quote: ... IL-23 (5 ng/ml, BioLegend), anti-mouse IL-4 (10 ug/mL ...
-
bioRxiv - Immunology 2023Quote: ... 5 μg/mL brefeldin A (Biolegend) was added to all wells to suspend ER–Golgi trafficking and block cytokine secretion ...
-
bioRxiv - Immunology 2023Quote: ... IL-7 (5 ng/ml, BioLegend) and IL-15 (5 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... Brefeldin A (5 μg/ml; Biolegend) was incubated with cells for 4 h ...
-
bioRxiv - Immunology 2024Quote: ... BFA (5 mg/mL) (Biolegend, 420601) and monensin (2 mM ...
-
bioRxiv - Immunology 2024Quote: ... brefeldin A (5 µg/mL; Biolegend), and monensin (2 µM ...
-
bioRxiv - Immunology 2021Quote: ... 2.1 mmol/L ultra-glutamine in the presence of Brefeldin A (5 μg/ml) and monensin (2 μM; BioLegend). After 5 hours of incubation ...
-
bioRxiv - Genetics 2021Quote: ... mouse anti-MBP (1:4.000; clone SMI 94/SMI 99, BioLegend); rabbit anti-MAG (1:1.000 ...
-
bioRxiv - Immunology 2021Quote: ... in culture medium supplemented with 0.5 µg/mL soluble anti-mouse CD28 (eBioscience) and 10 ng/mL (∼50 U/mL) recombinant murine Interleukin-2 (IL-2, BioLegend), and activated for up to 72h ...
-
bioRxiv - Immunology 2021Quote: ... IL-2 (20 ng/ml; BioLegend), IL-4 (20 ng/ml ...
-
bioRxiv - Immunology 2023Quote: ... 200 IU/ml IL-2 (Biolegend), 12.5% FBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 1ng/mL IL-2 (BioLegend) for 72 hr ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 0.5ng/mL IL-2 (BioLegend) for 72 hr at 37 °C ...
-
bioRxiv - Immunology 2022Quote: ... CD4+ T-cells were cultured alone or co-cultured with either of the B-cell populations at a ratio of 3:1 for 60 h at 37°C and 5% CO2 on anti-CD3 (2 μg/mL) (ULTRA-LEAF Biolegend) coated flat bottomed 384 CellCarrier Ultra microplates (PerkinElmer ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... and 5 μg/mL Brefeldin A (BioLegend). After 6 h ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... and 5 μg/mL Brefeldin A (BioLegend). After 6 h of incubation ...
-
bioRxiv - Immunology 2020Quote: ... with 5 μg/mL Brefeldin A (BioLegend) added to each well for the last 2.5 hours ...
-
bioRxiv - Immunology 2020Quote: ... αIL-12 (5 μg/ml; Biolegend, #505307) and αIFNγ (5 ug/ml ...
-
bioRxiv - Immunology 2020Quote: ... and αIFNγ (5 ug/ml; Biolegend, #505812), with or without 2.5 μM mCRAMP ...
-
bioRxiv - Immunology 2020Quote: ... 5 μg/ml Brefeldin A (Biolegend, 420601) was added to the culture for the last four hours of the incubation ...
-
bioRxiv - Immunology 2022Quote: ... 5 μg/ml soluble αCD28 mAb (BioLegend) plus 200 U/ml IL-2 (Miltenyi Biotec ...
-
bioRxiv - Immunology 2023Quote: ... 10 ng/mL IL-5 (581502, BioLegend) and 50 μM 2-Mercaptoethanol ...
-
bioRxiv - Immunology 2022Quote: ... and brefeldin A (5 μg/ml, BioLegend). After a 6-hour stimulation ...
-
bioRxiv - Bioengineering 2023Quote: ... and 5 μg/mL Brefeldin A (Biolegend). After incubation for 6 h ...